🔗 Share this article

Treasury head Rachel Reeves has announced she is planning "specific action to deal with household expense challenges" in the upcoming financial statement.

Speaking to the BBC, she stated that lowering price rises is a joint responsibility of both the administration and the central bank.

The UK's price growth is projected to be the most elevated among the Group of Seven industrialized countries this year and next.

Potential Utility Cost Interventions

Reports indicate the administration could intervene to lower utility costs, for instance by reducing the current 5% level of VAT applied on energy.

A further option is to reduce some of the policy costs presently included in bills.

Budgetary Constraints and Analyst Predictions

The government will obtain the next report from the official forecaster, the OBR, on Monday, which will reveal how much room there is for these actions.

The view from the majority of experts is that Reeves will have to declare tax increases or budget cuts in order to meet her declared debt limits.

Previously on Thursday, estimates suggested there was a twenty-two billion pound gap for the Treasury chief to address, which is at the more modest range of projections.

"It is a shared job between the central bank and the administration to bear down further on some of the causes of price increases," the Chancellor told the BBC in the US capital, at the annual meetings of the International Monetary Fund and global financial institution.

Revenue Commitments and International Issues

While a great deal of the focus has been on likely tax increases, the Treasury chief said the latest figures from the fiscal watchdog had not altered her commitment to election pledges not to raise tax levels on income tax, VAT or social security contributions.

She blamed an "unpredictable world" with growing international and trade tensions for the fiscal tax moves, likely to be targeted on those "wealthiest."

Global Economic Disputes

Referring to concerns about the UK's commercial links with the Asian nation she said: "The UK's national security invariably come first."

Last week's statement by Chinese authorities to strengthen trade restrictions on rare earths and other resources that are essential for high-technology manufacturing led US President the US President to threaten an additional 100% tariff on goods from China, raising the prospect of an all-out trade war between the two largest economies.

The American finance chief described China's move "economic coercion" and "a international production control attempt."

Inquired about accepting the US offer to join its dispute with China, Reeves said she was "very concerned" by China's measures and urged the Chinese government "to avoid restrictions and limit trade."

She said the move was "damaging for the international commerce and generates further challenges."

"In my view there are areas where we need to address Chinese policies, but there are also important chances to sell into Chinese markets, including financial services and other areas of the economy. We've got to maintain that equilibrium correct."

The chancellor also affirmed she was working with other major economies "on our own critical minerals plan, so that we are reduced dependence."

NHS Medicine Costs and Funding

The Chancellor also acknowledged that the price the NHS pays for drugs could increase as a consequence of current talks with the US government and its drugs companies, in return for lower tariffs and funding.

Some of the world's largest pharmaceutical manufacturers have said lately that they are either pausing or canceling operations in the UK, with some blaming the low prices they are getting.

Recently, the government science advisor said the cost the NHS spends on drugs would have to go up to stop firms and pharmaceutical investment departing from the UK.

The Chancellor stated to media: "We have seen due to the pricing regime, that drug testing, recent pharmaceuticals have not been offered in the UK in the way that they are in other continental states."

"Our aim is to make sure that patients receiving treatment from the NHS are can receive the finest essential medicines in the globe. And so we are examining all of that, and... aiming to obtain additional funding into Britain."